Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash from Financing Activities (2018 - 2025)

Health Catalyst's Cash from Financing Activities history spans 8 years, with the latest figure at -$434000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 101.15% year-over-year to -$434000.0; the TTM value through Dec 2025 reached -$235.8 million, down 255.38%, while the annual FY2025 figure was -$235.8 million, 255.38% down from the prior year.
  • Cash from Financing Activities reached -$434000.0 in Q4 2025 per HCAT's latest filing, up from -$537000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $248.8 million in Q3 2021 to a low of -$230.1 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $9.0 million, with a median of $951500.0 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: surged 10716.83% in 2024, then crashed 33065.47% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $3.9 million in 2021, then plummeted by 83.73% to $637000.0 in 2022, then crashed by 37.99% to $395000.0 in 2023, then skyrocketed by 9441.77% to $37.7 million in 2024, then tumbled by 101.15% to -$434000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Cash from Financing Activities are -$434000.0 (Q4 2025), -$537000.0 (Q3 2025), and -$230.1 million (Q2 2025).